Moderna (MRNA) Moves 13.1% Higher: Will This Strength Last?

Moderna (MRNA) shares soared 13.1% in the last trading session to close at $112.50. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 24.5% gain over the past four weeks.Share prices surged after analysts at Oppenheimer recently upgraded the stock’s recommendation to Outperform. Per these analysts, Moderna could become ‘a five-product commercial company by 2026’. These analysts were encouraged by Moderna’s upcoming product launches ...